SAT0159 Impact of participation in the adalimumab patient support program on functional and clinical outcomes among patients with rheumatoid arthritis: passion study
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.1876
Abstract: Background Patients (pt) with Rheumatoid arthritis (RA) who are treated with adalimumab (ADA) are offered a Patient Support Program (PSP) with variety of services. To date, no prospective study has been conducted to analyze the… read more here.
Keywords: abbvie; psp non; study; non users ... See more keywords
THU0190 Clinical outcomes among rheumatoid arthritis patients receiving adalimumab who did or did not participate in the patient support program: a subanalysis of the passion study
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.6754
Abstract: Background The AbbVie Patient (pt) Support Program (PSP) is offered to pts prescribed adalimumab (ADA) for rheumatoid arthritis (RA) and other indications. Objectives This subanalysis evaluated the impact of ADA in achieving clinical, functional, and… read more here.
Keywords: pfizer; psp; psp non; non users ... See more keywords
PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2020.00574
Abstract: Introduction: Frontotemporal lobar degeneration (FTLD)-related syndrome includes progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). PSP is usually caused by a tauopathy but can have associated Alzheimer's disease (AD) while CBS can be caused by… read more here.
Keywords: psp; group; psp non; motor ... See more keywords